LINC01287

Across TCGA pan-cancer cohorts, LINC01287 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated LINC01287 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher LINC01287 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01287 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LGG show a favorable association.

UVM, HNSC, and OV are the cancer types where LINC01287 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Quartile	All	0.652	1.000	<.001	67	view →
HNSC	OS	Tertile	III,IV	0.422	0.270	.004	54	view →
OV	OS	Quartile	All	0.252	0.377	.006	50	view →
LGG	DFS	Median	All	0.474	0.282	<.001	42	view →
STAD	DFS	Tertile	IV	0.156	0.853	<.001	38	view →
GBM	OS	Median	All	0.535	0.295	.004	27	view →
ACC	DFS	Median	III,IV	0.826	0.290	.001	25	view →
KIRP	OS	Median	All	0.557	0.784	.005	21	view →
THYM	DFS	Tertile	III,IV	1.000	0.232	.006	18	view →
LAML	DFS	Quartile	All	0.806	0.299	<.001	18	view →
LIHC	DFS	Quartile	All	0.446	0.635	.001	18	view →
SKCM	OS	Tertile	All	0.846	0.745	.001	17	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

LINC01287–UVM (OS)

Open the UVM breakdown →